Iteos Therapeutics Correlations

ITOS Stock

USD 10.13 0.13 1.27%

The current 90-days correlation between Iteos Therapeutics and Cullinan Oncology LLC is 0.26 (i.e., Modest diversification). The correlation of Iteos Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Iteos Therapeutics Correlation With Market

Significant diversification

The correlation between Iteos Therapeutics and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Iteos Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iteos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Iteos Stock please use our How to Invest in Iteos Therapeutics guide.

Moving together with Iteos Stock

0.8	PFE	Pfizer Inc	Pair Corr
0.7	KMDA	Kamada	Pair Corr
0.63	RCUS	Arcus Biosciences	Pair Corr
0.8	CGEN	Compugen	Pair Corr
0.69	FNMFO	Federal National Mortgage Earnings Call This Week	Pair Corr
0.73	AVAL	Grupo Aval	Pair Corr
0.93	KB	KB Financial Group	Pair Corr
0.89	SHG	Shinhan Financial Earnings Call This Week	Pair Corr
0.83	WF	Woori Financial Group Earnings Call Tomorrow	Pair Corr
0.88	CSCO	Cisco Systems	Pair Corr
0.86	IBM	International Business Earnings Call Tomorrow	Pair Corr
0.77	AA	Alcoa Corp	Pair Corr
0.86	MSFT	Microsoft Aggressive Push	Pair Corr
0.74	CVX	Chevron Corp	Pair Corr
0.87	DIS	Walt Disney	Pair Corr
0.8	AXP	American Express	Pair Corr

Moving against Iteos Stock

0.4

Coca Cola Earnings Call Today

Pair Corr

Related Correlations Analysis

	RCUS	CGEM	ANNX	GPCR	RLAY	NRIX	KYMR	PCVX	CCCC
RCUS		0.48	0.52	-0.24	0.37	0.41	0.53	0.59	0.38	RCUS
CGEM	0.48		0.16	0.12	0.08	0.38	0.24	0.41	-0.09	CGEM
ANNX	0.52	0.16		-0.62	0.81	0.8	0.89	0.63	0.47	ANNX
GPCR	-0.24	0.12	-0.62		-0.5	-0.56	-0.57	-0.26	-0.36	GPCR
RLAY	0.37	0.08	0.81	-0.5		0.83	0.81	0.7	0.72	RLAY
NRIX	0.41	0.38	0.8	-0.56	0.83		0.85	0.72	0.51	NRIX
KYMR	0.53	0.24	0.89	-0.57	0.81	0.85		0.67	0.51	KYMR
PCVX	0.59	0.41	0.63	-0.26	0.7	0.72	0.67		0.66	PCVX
CCCC	0.38	-0.09	0.47	-0.36	0.72	0.51	0.51	0.66		CCCC
	RCUS	CGEM	ANNX	GPCR	RLAY	NRIX	KYMR	PCVX	CCCC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

KYMR	+ 0.89	ANNX
KYMR	+ 0.85	NRIX
NRIX	+ 0.83	RLAY
RLAY	+ 0.81	ANNX
KYMR	+ 0.81	RLAY
NRIX	+ 0.8	ANNX

High negative correlations

GPCR	- 0.62	ANNX
KYMR	- 0.57	GPCR
NRIX	- 0.56	GPCR
RLAY	- 0.5	GPCR
CCCC	- 0.36	GPCR
PCVX	- 0.26	GPCR

Risk-Adjusted Indicators

There is a big difference between Iteos Stock performing well and Iteos Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Iteos Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RCUS	2.94	0.42	0.05	(0.47)	3.42	(3.09)	6.49	(6.42)	18.17
CGEM	2.57	(0.19)	0.00	(0.01)	0.00	0.00	4.81	(5.34)	16.72
ANNX	3.92	0.61	0.14	0.51	4.21	(4.31)	10.63	(7.86)	23.91
GPCR	2.58	0.01	(0.04)	0.02	3.23	(2.85)	6.16	(5.82)	25.49
RLAY	3.09	0.26	0.08	0.30	3.75	(3.16)	6.14	(6.35)	16.42
NRIX	2.88	0.09	0.04	0.20	3.31	(3.45)	7.16	(4.42)	21.48
KYMR	3.21	0.87	0.25	0.83	2.82	(3.80)	6.98	(4.46)	48.99
PCVX	2.99	0.11	0.05	0.21	3.48	(3.73)	6.93	(4.73)	21.28
CCCC	5.67	0.98	0.18	0.74	5.09	(6.83)	12.50	(8.59)	29.47

Iteos Therapeutics Corporate Management

Matthew Gall	Chief Officer	Profile
Matthew MBA	Chief Officer	Profile
Ryan Baker	Head Relations	Profile
Joanne MD	Chief Officer	Profile
Adi Osovsky	Executive Legal	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC